The Hematologist

In this podcast, ASH President Dr. Alexis Thompson has a conversation with Dr. Melody Smith about Dr. Smith's experience navigating the ASH career development and leadership pathways to help inspire aspiring hematologists and inform them of all the resources available through ASH. Learn more by visiting www.hematology.org/awards. **Apply for the ASH Minority Medical Student Award Program by Januar...

In this podcast, Contributing Editor Professor Paul Moss has a conversation with Professor Johnny Mahlangu. They discuss Dr. Moss's Diffusion article from the November/December 2018 issue of The Hematologist. The article titled, "Mimicry Not Replacement: Molecular Engineering Transforms the Outlook in Hemophilia A," covers the HAVEN3 study, which focuses on the activity of prophylactic emicizumab...

In this podcast, Dr. Robert Liem, Dr. Sophie Lanzkron, and Dr. Reem Mustafa discuss the clinical importance of ASH Guidelines on SCD, specifically the guideline opening September 24, 2018, for public comment, SCD-Related Cardiopulmonary and Kidney Disease. To access and comment on these guidelines, visit www.hematology.org/guidelines-public-comment. The comment period will open September 24 and cl...

In this podcast, Dr. Michael DeBaun and Dr. Hassan Murad discuss the clinical importance of ASH Guidelines on SCD, specifically the guideline opening September 24, 2018, for public comment, SCD-Related Cerebrovascular Disease. To access and comment on these guidelines, visit www.hematology.org/guidelines-public-comment. The comment period will open September 24 and close November 5, 2018. Addition...

In this podcast, Contributing Editor Dr. Annette Kim has a conversation with Dr. Davide Rossi. They discuss Dr. Kim's Diffusion article from the September/October 2018 issue of The Hematologist. The article titled, "Circulating Tumor DNA in Lymphoma Monitoring: Fantasy, Fad, or Fact?," covers a study that showcases the utility of circulating tumor DNA monitoring in classic Hodgkin lymphoma. You ca...

In this podcast, Dr. Stella Chou and Dr. Jo Howard discuss the clinical importance of ASH Guidelines on SCD, specifically the guideline opening August 20, 2018, for public comment, SCD-Related Transfusion Support. To access and comment on these guidelines, visit www.hematology.org/guidelines-public-comment. The comment period will open August 20 and close October 1, 2018. Additional ASH Guidelines...

In this podcast, former Chair of the ASH Trainee Council Dr. Leidy Isenalumhe and current Chair of the ASH Trainee Council Dr. Alex Boucher have a conversation about the re-imagined Trainee Day, now known as ASH-a-Palooza, taking place at the 2018 ASH Annual Meeting. ASH-a-Palooza will offer a relaxed, open learning environment for trainees in a festival-like setting with multiple opportunities fo...

In this podcast, Dr. David Anderson and Dr. Philipp Dahm discuss the clinical importance of new ASH Guidelines on VTE, specifically the guideline currently open for public comment, Prevention of VTE in Surgical Patients. To access and comment on these guidelines, visit www.hematology.org/guidelines-public-comment. The comment period closes July 25, 2018. Additional ASH Guidelines on VTE will becom...

In this podcast, Contributing Editor Dr. Omar Abdel-Wahab has a conversation with Drs. Ulrich Steidl and Amit Verma. They discuss Dr. Abdel-Wahab's Diffusion article from the July/August 2018 issue of The Hematologist. The article titled, "New Means to Reactivate p53 in Leukemia: A Staple Peptide Inhibitor of MDMX and MDM2," discusses therapeutic activation of wild-type TP53 in leukemia and other...

In this podcast, Chair of the ASH Committee on Practice Dr. Joseph Alvarnas and Chair of the ASH Committee on Government Affairs Dr. Alan Rosmarin talk about the ASH Congressional Fellowship, a unique opportunity for a hematologist to work in a congressional office on Capitol Hill for an academic year, to help shape health care and hematology policy. We also hear from Dr. Catherine Zander, the fir...

In this podcast, Contributing Editor Dr. Caron Jacobson and Dr. Marcela Maus both of Dana Farber Cancer Institute have a thought provoking conversation. They discuss Dr. Jacobson's Diffusion article from the May/June 2018 issue of The Hematologist. The article titled, "In Vivo and In-stantaneous Production of Chimeric Antigen Receptor T Cells: Overcoming Treatment Delays" talks about the in vivo a...

In this podcast, Chair of the ASH Committee on Practice Dr. Joseph Alvarnas has a conversation with Biosimilars Faculty Member Dr. Gary Lyman about the webinar series "Biosimilars: A New Era of Hematology/Oncology Management Considerations." They discuss the significance of these webinars for hematologists and their patients, as well as the importance of preparing clinicians with information that...

In this podcast, Contributing Editor Dr. Michael DeBaun of Vanderbilt University has a conversation with Dr. Joshua Field of BloodCenter of Wisconsin where they cover Dr. DeBaun's Diffusion article from the March/April 2018 issue of The Hematologist. The article titled "What We Know and Do Not Know About Chronic Pain in Adults With Sickle Cell Disease" discusses available information on recurrent...

In this podcast, Chair of the International Members Committee Dr. Theresa Coetzer has a conversation with Vice-Chair of the International Members Committee Dr. Eduardo Rego about ASH global initiatives and the impact they have on international hematologists and their patients, as well as the integral role ASH members play in making these programs a reality. Visit www.hematology.org/global to learn...

In this Year's Best podcast, Editor-in-Chief of The Hematologist Dr. Laura Michaelis of Medical College of Wisconsin has a conversation with Contributing Editor Dr. Omar Abdel Wahab of Memorial Sloan Kettering. They discuss Dr. Abdel-Wahab's Year's Best article, which appears in the January/February 2018 issue of The Hematologist, titled "A Landmark Year for FDA-Approved Therapies for Acute Myeloi...

In this podcast, Dr. Wendy Lim and Dr. Reem Mustafa discuss the clinical importance of new ASH Guidelines on VTE, specifically one of the guidelines now open for public comment, Diagnosis of VTE. To access and comment on these guidelines, visit www.hematology.org/guidelines-public-comment. The comment period is open from December 5, 2017 to January 15, 2018. For more information, visit www.hematol...

In this podcast, 2017 ASH News Daily Editor-in-Chief Dr. Saad Usmani has a conversation with Education Program Co-chair Dr. Laurie Sehn and Scientific Program Co-chair Dr. Andrew Weyrich about what to expect at the 59th ASH Annual Meeting and Exposition, taking place December 9-12, 2017, in Atlanta, Georgia. They talk about stimulating sessions to look forward to, new exciting features and feature...

In this podcast, Dr. Dan Witt and Dr. Mark Crowther discuss the clinical importance of new ASH Guidelines on VTE, specifically the guideline opening for public comment, Optimal Management of Anticoagulation Therapy. To access and comment on these guidelines, visit www.hematology.org/guidelines-public-comment. The comment period is open from December 5, 2017 to January 15, 2018. For more informatio...

In this podcast, Contributing Editor Dr. Omar Abdel-Wahab has a conversation with Dr. Luisa Cimmino and Dr. Maher Abdul-Hay of NYU School of Medicine. They discuss Dr. Abdel-Wahab's Diffusion article, which appears in the November/December 2017 issue of The Hematologist, titled "Vitamin C Treatment Restores TET2-Deficiency and Confers Sensitivity to PARP Inhibition." This thought-provoking convers...

In this podcast, Outgoing Editor-in-Chief of The Hematologist Dr. Jason Gotlib gives a warm welcome to Editor-in-Chief Designee Dr. Laura Michaelis. Dr. Michaelis' term begins in 2018. They discuss her vision for the publication including The Hematologist's digital presence, multimedia efforts, new columns, and untapped topics that require attention. Access The Hematologist online via www.hematolo...

In this podcast, Dr. Adam Cuker and Dr. Shannon Bates discuss the clinical importance of new ASH Guidelines on VTE. The two guidelines currently open for public comment are VTE in the Context of Pregnancy and Heparin-Induced Thrombocytopenia. The deadline to comment on these is October 2. To access and comment on these guidelines, visit www.hematology.org/guidelines-public-comment. For more inform...

In his Diffusion article from the September/October 2017 issue of The Hematologist, Dr. Jonathan Hoggatt discusses efforts to grow hematopoietic stem cells to care for patients with diseases that can be treated with bone marrow transplantation. He covers a Nature article co-authored by Dr. George Daley, Dean of Harvard Medical School. In this podcast, Dean Daley joins Dr. Hoggatt for a thought pro...

Part 1 (Dr. Cucker and Dr. Schünemann): Starts at 2:50 min. Part 2 (Dr. Cushman and Dr. Monagle): Starts at 26:00 min. In this podcast, Drs. Adam Cuker, Holger Schünemann, Mary Cushman and Paul Monagle talk about new ASH Guidelines on VTE, an ASH project started in 2015 to develop 10 evidence-based clinical practice guidelines on the diagnosis and treatment of venous thromboembolism (VTE), in coll...

In her Diffusion article from the July/August 2017 issue of The Hematologist, Dr. Lori-Ann Linkins takes a look at the EINSTEIN CHOICE Study and compares reducing the intensity of anticoagulant therapy or switching to aspirin as options for patients who wish to continue being protected from the risk of VTE. She covers a New England Journal of Medicine article co-authored by Dr. Jeffrey Weitz. In t...

In this podcast, Chair of the ASH Committee on Practice Dr. Joseph Alvarnas and Chair of the ASH Committee on Government Affairs Dr. Alan Rosmarin, update ASH members on key policy topics affecting hematologists. They discuss the current political climate and its effects on issues impacting the field of hematology, including research funding, drug access and pricing issues, and efforts to repeal t...